BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 10379420)

  • 21. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
    Taylor D
    Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective serotonin reuptake inhibitors for late-life depression: a comparative review.
    Solai LK; Mulsant BH; Pollock BG
    Drugs Aging; 2001; 18(5):355-68. PubMed ID: 11392444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
    Crewe HK; Lennard MS; Tucker GT; Woods FR; Haddock RE
    Br J Clin Pharmacol; 1992 Sep; 34(3):262-5. PubMed ID: 1389951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update.
    Hemeryck A; Belpaire FM
    Curr Drug Metab; 2002 Feb; 3(1):13-37. PubMed ID: 11876575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics and drug interactions of antidepressive agents].
    Sawada Y; Ohtani H
    Nihon Rinsho; 2001 Aug; 59(8):1539-45. PubMed ID: 11519155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
    Carrasco JL; Sandner C
    Int J Clin Pract; 2005 Dec; 59(12):1428-34. PubMed ID: 16351675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
    Eap CB; Baumann P
    J Chromatogr B Biomed Appl; 1996 Nov; 686(1):51-63. PubMed ID: 8953192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.
    Spina E; Santoro V; D'Arrigo C
    Clin Ther; 2008 Jul; 30(7):1206-27. PubMed ID: 18691982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic optimisation of therapy with newer antidepressants.
    Goodnick PJ
    Clin Pharmacokinet; 1994 Oct; 27(4):307-30. PubMed ID: 7834966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of selective serotonin reuptake inhibitors: clinical relevance.
    Catterson ML; Preskorn SH
    Pharmacol Toxicol; 1996 Apr; 78(4):203-8. PubMed ID: 8861776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of antidepressant medications. Based on a presentation by C. Lindsay DeVane, PharmD.
    Am J Manag Care; 2000 Feb; 6(2 Suppl):S39-46. PubMed ID: 10977427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are pharmacokinetic drug interactions with the SSRIs an issue?
    Brøsen K
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():23-7. PubMed ID: 8732441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Care of depression in the elderly: comparative pharmacokinetics of SSRIs.
    Baumann P
    Int Clin Psychopharmacol; 1998 Sep; 13 Suppl 5():S35-43. PubMed ID: 9817619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interaction between sumatriptan and selective serotonin uptake inhibitors].
    Pomp E
    Tidsskr Nor Laegeforen; 1998 Aug; 118(18):2809-10. PubMed ID: 9748814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically significant drug interactions with newer antidepressants.
    Spina E; Trifirò G; Caraci F
    CNS Drugs; 2012 Jan; 26(1):39-67. PubMed ID: 22171584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2001 Apr; 53(4):449-61. PubMed ID: 11341361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs.
    Mandrioli R; Protti M; Mercolini L
    Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability].
    Gury C; Cousin F
    Encephale; 1999; 25(5):470-6. PubMed ID: 10598311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?
    Rasmussen BB; Brøsen K
    Ther Drug Monit; 2000 Apr; 22(2):143-54. PubMed ID: 10774624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.